ATE181599T1 - Methode zur bestimmung von hämoglobinaddukten - Google Patents

Methode zur bestimmung von hämoglobinaddukten

Info

Publication number
ATE181599T1
ATE181599T1 AT94104399T AT94104399T ATE181599T1 AT E181599 T1 ATE181599 T1 AT E181599T1 AT 94104399 T AT94104399 T AT 94104399T AT 94104399 T AT94104399 T AT 94104399T AT E181599 T1 ATE181599 T1 AT E181599T1
Authority
AT
Austria
Prior art keywords
hemoglobin
determining
blood sample
hemoglobina
adducts
Prior art date
Application number
AT94104399T
Other languages
English (en)
Inventor
Kin-Fai Yip
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag filed Critical Bayer Ag
Application granted granted Critical
Publication of ATE181599T1 publication Critical patent/ATE181599T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/72—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood pigments, e.g. haemoglobin, bilirubin or other porphyrins; involving occult blood
    • G01N33/721—Haemoglobin
    • G01N33/723—Glycosylated haemoglobin
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/10—Composition for standardization, calibration, simulation, stabilization, preparation or preservation; processes of use in preparation for chemical testing
    • Y10T436/105831—Protein or peptide standard or control [e.g., hemoglobin, etc.]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Hematology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
AT94104399T 1993-04-02 1994-03-21 Methode zur bestimmung von hämoglobinaddukten ATE181599T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US4147193A 1993-04-02 1993-04-02
US08/077,546 US6043043A (en) 1993-04-02 1993-06-18 Method for the determination of hemoglobin adducts

Publications (1)

Publication Number Publication Date
ATE181599T1 true ATE181599T1 (de) 1999-07-15

Family

ID=26718171

Family Applications (1)

Application Number Title Priority Date Filing Date
AT94104399T ATE181599T1 (de) 1993-04-02 1994-03-21 Methode zur bestimmung von hämoglobinaddukten

Country Status (9)

Country Link
US (1) US6043043A (de)
EP (1) EP0618449B1 (de)
JP (1) JP3331251B2 (de)
AT (1) ATE181599T1 (de)
DE (1) DE69419192T2 (de)
DK (1) DK0618449T3 (de)
ES (1) ES2132272T3 (de)
FI (1) FI109557B (de)
NZ (1) NZ260084A (de)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7459127B2 (en) * 2002-02-26 2008-12-02 Siemens Healthcare Diagnostics Inc. Method and apparatus for precise transfer and manipulation of fluids by centrifugal and/or capillary forces
US7252980B2 (en) * 2002-08-06 2007-08-07 Metabolix Inc. Polymer extraction methods
EP1556695B1 (de) * 2002-09-03 2011-08-10 Bayer Technology Services GmbH Analytische plattform und nachweisverfahren mit gegebenenfalls nach fraktionierung in einer probe nachzuweisenden analyten als immobilisierten spezifischen bindungspartnern
US7125711B2 (en) * 2002-12-19 2006-10-24 Bayer Healthcare Llc Method and apparatus for splitting of specimens into multiple channels of a microfluidic device
US7094354B2 (en) * 2002-12-19 2006-08-22 Bayer Healthcare Llc Method and apparatus for separation of particles in a microfluidic device
US7435381B2 (en) * 2003-05-29 2008-10-14 Siemens Healthcare Diagnostics Inc. Packaging of microfluidic devices
US20040265172A1 (en) * 2003-06-27 2004-12-30 Pugia Michael J. Method and apparatus for entry and storage of specimens into a microfluidic device
US20080257754A1 (en) * 2003-06-27 2008-10-23 Pugia Michael J Method and apparatus for entry of specimens into a microfluidic device
US20040265171A1 (en) * 2003-06-27 2004-12-30 Pugia Michael J. Method for uniform application of fluid into a reactive reagent area
US7347617B2 (en) * 2003-08-19 2008-03-25 Siemens Healthcare Diagnostics Inc. Mixing in microfluidic devices
CA2510277C (en) * 2003-09-23 2012-07-24 Epinex Diagnostics, Inc. Rapid test for glycated albumin
US7150995B2 (en) * 2004-01-16 2006-12-19 Metrika, Inc. Methods and systems for point of care bodily fluid analysis
CN101160527B (zh) * 2005-04-14 2013-04-03 松下电器产业株式会社 血红蛋白衍生物的测定方法、该法中使用的试剂组合物、测定试剂盒、分析设备以及分析系统
US8574913B2 (en) * 2007-10-30 2013-11-05 Panasonic Corporation Method for measurement of hemoglobin and hemoglobin derivative, and measurement kit
ES2541114T3 (es) * 2007-11-20 2015-07-16 Siemens Healthcare Diagnostics Inc. Métodos para la detección de hemoglobina glicosilada
US20100167306A1 (en) * 2008-12-26 2010-07-01 Henry John Smith Rapid test for glycated albumin in saliva
US8603828B2 (en) 2009-11-18 2013-12-10 Bio-Rad Laboratories, Inc. Multiplex immunoassays for hemoglobin, hemoglobin variants, and glycated forms
WO2017195838A1 (ja) * 2016-05-13 2017-11-16 栄研化学株式会社 測定対象物質の比較対象物質に対する割合を求める方法、プログラム、記憶媒体及び装置
EP3821257A4 (de) * 2018-07-13 2021-11-03 Siemens Healthcare Diagnostics, Inc. Verfahren zur detektion von aberranten ergebnissen durch unvollständige dispersion eines immunoassay-reagens
WO2020167411A1 (en) 2019-02-15 2020-08-20 Siemens Healthcare Diagnostics Inc. Calibrators and controls for the determination of percent glycated hemoglobin in a patient's liquid test sample
CN113825984B (zh) * 2019-05-20 2024-08-13 美国西门子医学诊断股份有限公司 用于检测免疫测定中由多半抗原试剂的不完全递送引起的异常结果的方法
WO2020264513A1 (en) * 2019-06-27 2020-12-30 Case Western Reserve University Compositions and methods for blood and anemia detection

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4658022A (en) * 1985-08-08 1987-04-14 Molecular Diagnostics, Inc. Binding of antibody reagents to denatured protein analytes
US4837170A (en) * 1986-01-20 1989-06-06 Otsuka Pharmaceutical Co., Ltd. Monoclonal antibody, measuring method of glucosylated protein by utilizing the monoclonal antibody, and kit therefor
US4835097A (en) * 1986-10-15 1989-05-30 Saunders Alexander M Method for ascertaining the history of a condition of the body from a single blood sample
US4970171A (en) * 1987-11-09 1990-11-13 Miles Inc. Denaturant reagents for convenient determination of hemoglobin derivatives in blood

Also Published As

Publication number Publication date
FI941522L (fi) 1994-10-03
ES2132272T3 (es) 1999-08-16
EP0618449A1 (de) 1994-10-05
NZ260084A (en) 1995-02-24
EP0618449B1 (de) 1999-06-23
JPH06308122A (ja) 1994-11-04
DE69419192D1 (de) 1999-07-29
FI109557B (fi) 2002-08-30
DK0618449T3 (da) 1999-12-06
US6043043A (en) 2000-03-28
FI941522A0 (fi) 1994-03-31
DE69419192T2 (de) 1999-11-04
JP3331251B2 (ja) 2002-10-07

Similar Documents

Publication Publication Date Title
ATE181599T1 (de) Methode zur bestimmung von hämoglobinaddukten
DE59710488D1 (de) Vorrichtung und Verwendung einer Vorrichtung zur Bestimmung der Konzentration von Hämoglobinderivaten in einer unverdünnten, unhämolysierten Vollblutprobe
ATE193378T1 (de) Immunologische methode zur bestimmung von hbaic
FI904534A0 (fi) Foerfarande och anordning foer amperometrisk diagnosanalys.
DE68910758D1 (de) Bestimmung mit Affinitätssubstanzen und HPLC-Schritt.
ATE146952T1 (de) Verfahren zur nichtinvasiven periodischen und/oder kontinuierlichen bestimmung von hämoglobin , arteriellem sauerstoffgehalt und hämatokrit
DE3788762D1 (de) Verfahren zur Bestimmung von physiologisch wirksamen Substanzen.
DE59208032D1 (de) Funktioneller Test und Reagenz zur Bestimmung von Fibrinogen
FI881704A7 (fi) Menetelmä ja laite analyyttitason määrittämiseksi kokoverinäytteestä.
DK0681590T3 (da) Antikoagulerende sammensætning
ATE12318T1 (de) Verfahren und reagenz zur bestimmung von glykosiliertem haemoglobin.
ATE151532T1 (de) Quantitative bestimmung von mustern durch kapillare elektrophorese
ATE113663T1 (de) Reagenz zum nachweis und zur quantitativen bestimmung von leukozyten in biologischen flüssigkeiten und verfahren zu seiner verwendung.
DE3765147D1 (de) Verfahren und reagenz zur bestimmung von gesamt-bilirubin.
FI841145A7 (fi) Menetelmä hemoglobiinipitoisuuden kvantitatiiviseksi määrittämiseksi biologisessa näytteessä.
ATE135746T1 (de) Enzymatisches verfahren zur bestimmung der analyt-konzentration
ATE64470T1 (de) Verfahren und zusammensetzungen zur bestimmung von heparin.
ATE147861T1 (de) Funktioneller test zur bestimmung der protein s- aktivität
ATE208505T1 (de) Verfahren und reagenz zur überwachung des blutspiegels von antiplättchen-verbindungen
DE69922213D1 (de) Verfahren und testsatz zur bestimmung der analytkonzentration im blut
CA2118752A1 (en) Method for the Determination of Hemoglobin Adducts
DE59202364D1 (de) Verfahren zur quantitativen Bestimmung von krankheitsspezifischen Antigenen und Vorrichtung zur Durchführung des Verfahrens.
DE69425394D1 (de) Überwachung von Patienten mit Lungenkrebs durch Messung von NCA 50/90 im Blut
ATE57022T1 (de) Verfahren zur bestimmung von parathormon.
DE69128193D1 (de) Verfahren zur bestimmung von gesamtem kalzium unter verwendung eines verdünnungsmittels

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties